Some glucose-lowering drugs reduce risk for major adverse cardiac events.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32687745.
- Also identified by DOI 10.7326/ACPJ202007210-010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Zhu J, Yu X, Zheng Y, et al. <b>Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map.</b> Lancet Diabetes Endocrinol. 2020;8:192-205. 32006518.
Medical subject headings
- Glucose
- Sodium-Glucose Transporter 2 Inhibitors